Edition:
United States

Molecular Medicine SpA (MLMD.MI)

MLMD.MI on Milan Stock Exchange

0.48EUR
18 Jun 2018
Change (% chg)

€-0.00 (-0.21%)
Prev Close
€0.48
Open
€0.48
Day's High
€0.49
Day's Low
€0.48
Volume
121,448
Avg. Vol
2,519,006
52-wk High
€0.60
52-wk Low
€0.40

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 240.92 34.18
P/E High - Last 5 Yrs. -- 292.40 47.65
P/E Low - Last 5 Yrs. -- 101.52 25.16
Beta 0.90 0.73 0.78
Price to Sales (TTM) 8.93 277.70 8.57
Price to Book (MRQ) -- 23.83 4.35
Price to Tangible Book (MRQ) -- 31.28 6.03
Price to Cash Flow (TTM) -- 141.17 22.78
% Owned Institutions -- 10.77 2.40

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.67
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 2.24 -6.56
Payout Ratio(TTM) -- 42.16 39.28

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 47.93 24.66 5.00
Sales (TTM) vs TTM 1 Yr. Ago 31.76 138.03 12.50
Sales - 5 Yr. Growth Rate 38.01 30.82 7.91
EPS (MRQ) vs Qtr. 1 Yr. Ago 68.00 -77.30 40.63
EPS (TTM) vs TTM 1 Yr. Ago 56.06 -- --
EPS - 5 Yr. Growth Rate -- 48.49 8.03
Capital Spending - 5 Yr. Growth Rate 43.29 36.28 7.42

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.67 2.56
Current Ratio (MRQ) -- 6.39 3.64
LT Debt to Equity (MRQ) -- 20.82 12.92
Total Debt to Equity (MRQ) -- 25.11 17.37
Interest Coverage (TTM) -330.27 -142.62 35.97

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 78.46 56.39 54.96
Gross Margin - 5 Yr. Avg. 73.45 54.91 52.86
EBITD Margin (TTM) -16.15 -- --
EBITD - 5 Yr. Avg -93.12 -171.18 15.70
Operating Margin (TTM) -23.14 -947.86 -0.76
Operating Margin - 5 Yr. Avg. -99.63 -184.89 10.94
Pre-Tax Margin (TTM) -24.46 -831.06 1.32
Pre-Tax Margin - 5 Yr. Avg. -101.69 -188.29 11.12
Net Profit Margin (TTM) -24.46 -824.15 -1.97
Net Profit Margin - 5 Yr. Avg. -101.69 -186.71 7.48
Effective Tax Rate (TTM) -- 15.20 29.90
Effective Tax Rate - 5 Yr. Avg. -- 19.22 24.12

Efficiency

  Company industry sector
Revenue/Employee (TTM) 134,016 21,950,230 736,829,609
Net Income/Employee (TTM) -32,784 -523,802 85,814,668
Receivable Turnover (TTM) -- 18.22 6.06
Inventory Turnover (TTM) -- 2.86 3.65
Asset Turnover (TTM) -- 0.48 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -3.98 10.37
Return on Assets - 5 Yr. Avg. -37.49 -1.14 11.09
Return on Investment (TTM) -- -5.87 13.17
Return on Investment - 5 Yr. Avg. -59.34 1.58 14.39
Return on Equity (TTM) -- -7.71 15.15
Return on Equity - 5 Yr. Avg. -74.14 -3.84 15.73
  1 Year 3 Year 5 Year
Sales % 18.05 27.18 38.01
EPS (TTM) % 39.58 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Molecular Medicine SpA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.62 3.24 95 72
13 Week -1.52 1.29 99 24
26 Week 4.33 4.26 99 82
52 Week 14.03 7.64 99 83
YTD 1.89 0.87 99 79
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.99%
# of Holders: 14
Total Shares Held: 13,840,062
3 Mo. Net Change: -3,195,656
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 0
# Reduced Positions: 5
# Net Buyers: -5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.